The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer

Keyphrases

• Ovarian Cancer 100%
• Diagnostic Marker 100%
• Prognostic Marker 100%
• Oncogenic Fusion 100%
• TMPRSS2-ERG 100%
• Prostate Cancer 75%
• Overexpression 75%
• Endothelial Cells 50%
• Prostate Carcinoma 50%
• ERG Expression 50%
• Prostate Tumor 25%
• Histological Subtypes 25%
• Expression Profile 25%
• Androgens 25%
• Immunohistochemical Analysis 25%
• ETS Transcription Factors 25%
• Tissue Microarray 25%
• Gene Fusion 25%
• Pathological Type 25%
• Ovarian Tumor 25%
• Pathology Report 25%
• Tumor Patients 25%
• Ovarian Carcinoma 25%
• Gene Rearrangement 25%
• Ovarian Cancer Patients 25%
• Chromosomal Rearrangements 25%
• Novel Diagnostics 25%
• Tumor Cancer 25%
• TMPRSS2-ERG Fusion 25%
• Ovarian Tissue 25%
• Positive Expression 25%
• Patient Screening 25%
• Internal Positive Control 25%
• Carcinoma Progression 25%
• TMPRSS2 Gene 25%

Medicine and Dentistry

• Oncogene 100%
• Ovarian Cancer 100%
• Gene Fusion 100%
• Prostate Cancer 50%
• Endothelial Cell 33%
• Prostate Carcinoma 33%
• Diagnostic Marker 33%
• Malignant Neoplasm 16%
• Prostate Tumor 16%
• Carcinogenesis 16%
• Androgen 16%
• Tissue Microarray 16%
• Gene Rearrangement 16%
• Krukenberg Tumor 16%
• Ovarian Tumor 16%
• Transcription Factor ERG 16%